Although the tumor incidence rates and tumor volumes vastly differed between treatment groups, most importantly once the tumors did present the rate of proliferation, assessed using Ki67, was identical across all treatment groups (Fig. 5H). The gene discussed is MKI67; the disease is neoplasm.